Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.

Illustration of cilia

Published in the journal Arthritis and Rheumatologythe study looked at the role of proteins associated with primary cilia in post-natal cartilage development, and the health of adult cartilage.  

Angus Wann, KTRR/Versus Arthritis Research Fellow and senior author said: Wobserved a thinning of the cartilage that was due to the removal of a ‘brake’ which is dampening a developmental biological program to ensure the formation of cartilage that is fit for purpose for life-long mechanical loading.”  

The ‘brake’ was shown to be theprotein IFT88, found in the cilia. The developmental pathway (Hh signalling) being kept in check by IFT88 is also abnormally activated in human OA and the group found exercise restored normal levels of Hh signalling when cilia are disruptedAbnormal responses to mechanical forces underlie many diseases of cartilage and bone. Our results suggest that cilia may help integrate biological signalling with mechanical inputs to maintain healthy adult cartilage,” said Angus. “Ultimately, we have shown primary cilia are still very important in the adult knee, safeguarding cartilage integrity.   

The team is now working to understand how cells in cartilage use cilia to make the “right” decisions supporting healthy biological signalling in the face of what might otherwise be disease-causing challenges to the tissue.  

Understanding how cells use cilia to help them respond appropriately to signals such as mechanical forces, will help the understanding why many cartilage and bone disorders develop and identify new ways to protect against this.   

This research was primarily funded by the Kennedy Trust through a fellowship to Angus and studentship to Clarissa Coveney, and was also heavily supported by Versus Arthritis through the Centre for OA pathogenesis. 

 

Similar stories

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

Professor Chris Buckley has joined the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

Behind enemy lines: research finds a new ally in the fight against cardiovascular disease hidden within the vessel wall itself

A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters “good” macrophage behaviour within the vessel wall.

More effective treatment found for patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

NDORMS researchers honoured in the Recognition Of Distinction Scheme 2021

Sally Hopewell and John Christianson have been awarded the title of ‘Full Professor’ in the University of Oxford’s Recognition Of Distinction Scheme 2021.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.